A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia-Reference-Cited by-同舟云学术

A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia

Published:2018-09 Issue: Volume:129 Page:79-90
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Arantes Luiz H.^ORCID,Crawford Jeffrey,Gascon Pere,Latymer Mark,Launay-Vacher Vincent,Rolland Catherine,Scotte Florian,Wish Jay

Funder

Pfizer

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference78 articles.

1. Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis;Aapro;Br. J. Cancer,2006

2. Anemia of chronic kidney disease;Abbasi;Austin J. Clin. Med.,2014

3. Methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa for anemia in non-dialysis-dependent CKD: a systematic review;Alsalimy;Int. J. Clin. Pharm.,2014

4. Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia;Barosi;Br. J. Cancer,1998

5. Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European cancer anaemia survey;Barrett-Lee;Oncology,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of myelosuppression on quality of life of patients treated with chemotherapy;Future Oncology;2024-04-25

2. Supportive Care in Older Lymphoma Patients to Reduce Toxicity and Preserve Quality of Life;Cancers;2023-11-13

3. Evaluation of the results and cost of drug therapy for anemia in patients with 5th stage of the chronic kidney disease receiving hemodialysis in the real clinical practice in Moscow;Profilakticheskaya meditsina;2023

4. A Full Target-Mediated Drug Disposition (TMDD) Model to Explain the Changes in Recombinant Human Erythropoietin (rhEpo) Pharmacokinetics in Patients with Different Bone Marrow Integrity Following Hematopoietic Transplantation;Journal of Pharmaceutical Sciences;2022-09

5. COST-MINIMIZATION ANALYSIS OF USING SHORT AND LONG-ACTING ERYTHROPOESIS-STIMULATING AGENTS FOR CORRECTION OF NEPHROGENIC ANEMIA AGAINST THE BACKGROUND OF SUBSTITUTION THERAPY;Pharmacy & Pharmacology;2021-10-25